CEO: Brian Carrico

Visit Website

NeurAxis is an Indiana-based medical technology firm working to develop medical devices in the emerging science of neuromodulation.

They have market approval for the first-ever therapy (IB-Stim®) for functional abdominal pain, associated with IBS, in children. Through innovation and research, NeurAxis is also working to expand the number of approved indications for this technology, including pediatric functional nausea and post-concussion syndrome - conditions for which there are currently few effective treatments.